Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Orbimed Advisors LLC | 10% Owner | 2025-04-24 | 68,195 | $0.32 | $21.82kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-23 | 89,328 | $0.34 | $30.37kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-22 | 78,049 | $0.34 | $26.54kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-17 | 77,090 | $0.33 | $25.44kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-16 | 61,638 | $0.33 | $20.34kSell |
Orbimed Advisors LLC | 10% Owner | 2025-04-15 | 10,326 | $0.38 | $3.92kSell |
Kathleen Borthwick | CFO | 2025-02-11 | 3,183 | $0.53 | $1.69kSell |
Orbimed Advisors LLC | 10% Owner | 2025-01-14 | 79,024 | $0.60 | $47.41kSell |
Orbimed Advisors LLC | 10% Owner | 2025-01-13 | 17,986 | $0.64 | $11.51kSell |
Orbimed Advisors LLC | 10% Owner | 2025-01-10 | 126,209 | $0.66 | $83.30kSell |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Orbimed Advisors LLC | 20.27% | 12,597,323 | $4.11M | Insider |
Lynx1 Capital Management LP | 14.89% | 9,256,953 | $3.02M | Insider |
Lynx1 Capital Management LP | 14.89% | 9,256,953 | $3.02M | Institution |
Orbimed Advisors LLC | 11.91% | 7,404,869 | $2.41M | Institution |
Vestal Point Capital LP | 9.82% | 6,100,000 | $1.99M | Institution |
Patrick J. Heron | 8.06% | 5,009,219 | $1.63M | Insider |
Frazier Life Sciences IX LP | 8.06% | 5,009,219 | $1.63M | Insider |
Versant Venture Capital VI LP | 7.98% | 4,959,769 | $1.62M | Insider |
Thomas Woiwode | 7.98% | 4,959,769 | $1.62M | Insider |
Liam Ratcliffe | 4.21% | 2,619,430 | $853.93k | Insider |